Definition

What Is Bipolar Disorder?

Bipolar disorder is a chronic mood disorder defined by the recurrent alternation between manic or hypomanic episodes, characterized by elevated or irritable mood, decreased need for sleep⁴, racing thoughts, and impulsive behavior, and depressive episodes involving profound sadness, anhedonia, fatigue, and cognitive impairment.

The neurobiological underpinnings are multifactorial: dysregulation of dopamine, serotonin, and glutamate neurotransmission; hypothalamic-pituitary-adrenal (HPA) axis hyperactivation; mitochondrial energy failure in neurons; and a bidirectional relationship with systemic and neuroinflammation. Circadian rhythm disruption is both a trigger and consequence of mood episodes.

The gut-brain axis connection is increasingly recognized as central to bipolar pathology. Patients with bipolar disorder show significantly altered gut microbiome composition, increased intestinal permeability ("leaky gut"), and elevated inflammatory cytokines (IL-6, TNF-α, CRP) during both manic and depressive phases, suggesting that gut-driven neuroinflammation actively destabilizes the bipolar brain.

⚠️ Important: Bipolar disorder requires professional psychiatric diagnosis and monitoring. Antidepressants used alone, without a mood stabilizer, can trigger manic episodes³ or rapid cycling in bipolar patients. Never discontinue psychiatric medications without physician guidance. Nutritional strategies described here are complementary and evidence-informed, not replacements for psychiatric care.

Bipolar disorder, mood and brain health illustration

Types of Bipolar Disorder

⚡ Bipolar I

Defined by at least one full manic episode lasting ≥7 days (or any duration if hospitalization is required). Mania in Bipolar I can include psychotic features, hallucinations or delusions, and is severe enough to cause marked functional impairment. Depressive episodes are common but not required for diagnosis. The most severe and recognizable form. Affects men and women equally.

🌊 Bipolar II

Characterized by hypomanic episodes (4+ days; elevated/irritable mood that does not cause severe impairment or psychosis) and major depressive episodes. No full manic episodes. Often misdiagnosed as unipolar depression, patients typically present during depression, not hypomania. Depression dominates the illness burden (90% of symptomatic time). More common in women and often co-occurs with anxiety, eating disorders, and ADHD.

🔄 Cyclothymia & Rapid Cycling

Cyclothymia involves numerous hypomanic and depressive symptoms over ≥2 years that never meet full episode criteria, a chronic mood instability subtype. Rapid cycling (≥4 mood episodes per year) occurs in 15–20% of bipolar patients, is more common in women, and is associated with thyroid dysfunction, antidepressant overuse, alcohol use, and severe nutritional deficiencies. Nutritional optimization significantly improves cycle frequency.

Symptoms & Phases

Manic, Hypomanic & Depressive Episodes

Bipolar disorder manifests across two distinct mood poles, each with characteristic symptoms, triggers, and neurobiological profiles. Understanding both poles is essential for recognizing and managing the condition.

⚡ Manic / Hypomanic Phase

💡

Elevated or Irritable Mood

Persistently elevated, expansive, or irritable mood lasting at least 4 days (hypomania) or 7 days (mania). Can feel euphoric, invincible, or unusually creative, or, particularly in adolescents and males, present as marked irritability, agitation, and hostility rather than euphoria.

🚀

Decreased Need for Sleep & Racing Thoughts

One of the most diagnostically specific features: sleeping only 2–4 hours yet feeling rested and energized. Accompanied by racing, rapid thoughts (flight of ideas), rapid speech (pressured speech), increased goal-directed activity, and the subjective feeling that thoughts are moving faster than they can be expressed.

🎰

Impulsivity & Risk-Taking

Excessive involvement in pleasurable activities with high potential for harm: spending sprees, sexual indiscretion, reckless driving, impulsive business decisions, substance use. Driven by hyperdopaminergic state, the reward system is dysregulated, removing normal risk-aversion. A single manic episode can cause lasting financial, legal, or relational damage.

🌀

Grandiosity & Psychosis (Mania)

Inflated self-esteem or grandiosity, believing one has special powers, connections, or missions. In full mania, psychotic features (delusions of grandeur, persecutory delusions, hallucinations) may emerge. The person typically lacks insight during the episode, a critical challenge in treatment adherence. Hospitalization is sometimes required for safety.

🌑 Depressive Phase

💧

Profound Anhedonia & Sadness

Persistent depressed mood and loss of interest or pleasure in all (or nearly all) activities (anhedonia) for most of the day, nearly every day. Bipolar depression is often deeper and more persistent than unipolar depression, and is associated with higher rates of suicidal ideation. It accounts for the majority of functional impairment in bipolar disorder.

🧠

Cognitive Impairment & "Brain Fog"

Difficulty concentrating, forgetfulness, slowed thinking, and impaired executive function (planning, organizing, decision-making). Cognitive deficits often persist between episodes (euthymia) and represent a core feature, not just a symptom, driven by mitochondrial dysfunction, chronic inflammation, and cumulative neuroplastic changes.

⚡

Fatigue & Psychomotor Changes

Severe fatigue and loss of energy, often out of proportion to activity level. Psychomotor retardation (slowed movements, speech, and thinking) or, paradoxically, psychomotor agitation (restlessness, inability to sit still). Hypersomnia (sleeping 10–14 hours) is more common in bipolar depression than in unipolar depression.

⚠️

Suicidality

Bipolar disorder carries the highest suicide risk of any psychiatric diagnosis, 20–30x higher than the general population. Risk is greatest during depressive episodes and mixed states (simultaneous manic energy + depressive despair). If you or someone you know is in crisis, contact a mental health professional or emergency services immediately.

Root Cause

The Gut-Brain Axis, Inflammation & Mitochondria in Bipolar

The neurobiological drivers of bipolar disorder extend far beyond neurotransmitter imbalance, gut dysbiosis, neuroinflammation, and mitochondrial dysfunction form a triad that nutritional medicine can directly address.

🦠 Gut Microbiome Dysbiosis

Multiple studies show significantly altered gut microbiome composition in bipolar disorder, reduced Faecalibacterium prausnitzii (a key anti-inflammatory producer), decreased microbial diversity, and increased pathobiont species. These changes impair gut-derived serotonin and BDNF (brain-derived neurotrophic factor) synthesis, disrupt the enteric nervous system, and drive systemic inflammation that reaches the brain via the vagus nerve and bloodstream.

🔥 Neuroinflammation

Elevated inflammatory markers (IL-6, IL-1β, TNF-α, CRP) are consistently found in bipolar patients during both manic and depressive episodes, and to a lesser degree even during euthymia. Neuroinflammation disrupts glutamate-GABA balance, impairs the HPA axis feedback loop, reduces BDNF, and damages prefrontal cortical function. Gut leakiness allows bacterial lipopolysaccharides (LPS) to enter circulation and activate central microglia, fueling brain inflammation directly.

⚡ Mitochondrial Dysfunction

The brain consumes 20% of the body's energy despite being 2% of its mass. Neurons depend entirely on mitochondrial ATP production for synaptic function, ion gradient maintenance, and neurotransmitter synthesis. Bipolar patients show documented mitochondrial abnormalities in neural tissue, reduced complex I and IV activity, impaired oxidative phosphorylation, and increased mitochondrial DNA mutations. This directly impairs mood regulation circuits in the prefrontal cortex, amygdala, and hippocampus.

Assessment

Diagnostic Tools & Functional Lab Testing

Bipolar disorder diagnosis is clinical, based on DSM-5 criteria and longitudinal mood tracking. Functional labs identify underlying nutritional deficiencies and inflammatory drivers that directly influence mood stability.

📋 Clinical Assessment Tools

📔 Mood Charting (Daily Mood Log)

The most critical self-monitoring tool. Daily tracking of mood (–3 to +3 scale), sleep hours, energy level, medications, menstrual cycle, alcohol/substance use, and significant life events over months reveals mood patterns, cycle frequency, triggers, and early warning signs of emerging episodes. The NIMH Life Chart Method and smartphone apps (eMoods, Bearable) make this accessible.

📊 MDQ & YMRS Screening

The Mood Disorder Questionnaire (MDQ) is a validated 13-item self-report screen for bipolar spectrum disorders, sensitivity 0.73, specificity 0.90 for Bipolar I. The Young Mania Rating Scale (YMRS) quantifies manic symptom severity across 11 items. The PHQ-9 assesses depressive severity. These structured tools supplement clinical interview, bipolar is frequently misdiagnosed as unipolar depression when the hypomanic history is missed.

🧠 Neuropsychological Assessment

Formal cognitive testing (THINC-it, MATRICS) measures executive function, working memory, processing speed, and verbal learning, all commonly impaired in bipolar disorder even during euthymia. Establishing a cognitive baseline allows tracking of improvements with nutritional intervention and medication adjustments over time.

🔬 Functional & Nutritional Lab Panel

🐟 Omega-3 Index

The Omega-3 Index (EPA + DHA as % of RBC fatty acids) measures membrane omega-3 status, the most clinically meaningful measurement. Target: >8%. The vast majority of bipolar patients have an Omega-3 Index below 4%, more than 60% below optimal. Low omega-3 index is correlated with lower BDNF, greater neuroinflammation, worse depressive severity, and higher suicide risk.

🧬 Inflammatory & Nutritional Markers

High-sensitivity CRP (hs-CRP), IL-6, homocysteine (elevated in MTHFR polymorphism, strongly associated with mood disorders), Vitamin D 25(OH)D, RBC magnesium (serum magnesium misses intracellular depletion), serum zinc, plasma folate + active B12, and ferritin. These deficiencies are both consequences of bipolar disorder AND drivers of mood instability, a vicious cycle that nutrition breaks.

🦋 Thyroid Panel & Lithium Levels

Full thyroid panel (TSH, Free T3, Free T4, anti-TPO antibodies), thyroid dysfunction is highly comorbid with bipolar disorder and is a primary driver of rapid cycling. Lithium therapy (when used) requires regular serum lithium monitoring (therapeutic range 0.6²–1.2 mEq/L) plus kidney function (creatinine, eGFR) and calcium levels. Subclinical hypothyroidism from lithium use must be identified and treated.

Treatment Comparison

Holistic vs. Conventional Treatment for Bipolar Disorder

🌿 HOLISTIC

💊 CONVENTIONAL

🌿

Holistic / Functional Approach

Omega-3 fatty acids, NAC, Magnesium, gut healing, circadian rhythm optimization, anti-inflammatory nutrition

Omega-3 Evidence

Multiple RCTs show EPA-dominant omega-3 significantly reduces bipolar depressive symptoms, Cochrane review supports adjunctive use

NAC Evidence

N-Acetyl Cysteine (NAC) reduces bipolar depression severity by 30–40% in a placebo-controlled trial (Berk et al., 2008); reduces oxidative stress and neuroinflammation

Timeline

NAC effects visible in 8 weeks; omega-3 membrane incorporation requires 3 months for full effect

Advantage

Addresses neuroinflammation, mitochondrial dysfunction, and gut dysbiosis, the biological foundations driving mood instability

Full Holistic Support Protocol

Omega-3 fatty acids, the most evidence-supported nutritional intervention for bipolar depression; reduces neuroinflammation, restores membrane fluidity, and increases synaptic plasticity. Use triglyceride-form fish oil for best absorption.
N-Acetyl Cysteine (NAC, per your prescriber), the glutathione precursor; reduces oxidative stress and neuroinflammation; multiple RCTs show 30–40% reduction in bipolar depressive symptoms with zero serious adverse effects
Magnesium glycinate, reduces glutamate-driven excitotoxicity via NMDA receptor modulation; calms the hyperactive nervous system in hypomania; improves sleep architecture; deficient in the majority of bipolar patients
Lithium orotate (low-dose, per your prescriber), the orotate chelate form provides trace neuroprotective lithium without the toxicity risk of prescription lithium; research suggests neuroprotective effects on BDNF synthesis and GSK-3β inhibition at sub-therapeutic doses
Methylated B complex (methylfolate + methylcobalamin), corrects MTHFR-driven hyperhomocysteinemia, which is strongly associated with mood disorder severity and cognitive decline; active folate directly supports monoamine neurotransmitter synthesis
Vitamin D3 + K2, Vitamin D receptors are present throughout the limbic system; low Vitamin D correlates with greater depression severity, anxiety, and cognitive impairment in bipolar patients
Zinc, regulates NMDA receptor function and BDNF synthesis; low zinc is found in bipolar depression; has antidepressant properties in meta-analyses
Gut healing protocol, remove inflammatory foods (gluten sensitivity is elevated in bipolar patients), support gut barrier with L-glutamine and zinc carnosine, restore microbiome diversity with targeted probiotics (Lactobacillus rhamnosus, Bifidobacterium longum shown to reduce cortisol and improve mood in clinical trials)
Circadian rhythm entrainment, consistent sleep/wake time (7 days/week), morning light exposure (10,000 lux for 20 min), blue light restriction after 9pm; circadian disruption is both the most potent trigger AND a core pathological feature of bipolar disorder

✅ Integration note: These nutritional strategies are adjunctive to, not replacements for, psychiatric medications in bipolar disorder. Many patients successfully reduce medication dose or improve mood stability by combining evidence-based nutrition with psychiatric care. Always implement with the knowledge and supervision of your psychiatrist.

💊

Conventional / Medical Approach

Lithium, valproate, lamotrigine, atypical antipsychotics, quetiapine, psychotherapy (CBT, IPSRT)

Gold Standard

Lithium carbonate, the only medication proven to reduce suicide risk in bipolar disorder; first-line for Bipolar I and long-term maintenance

Mood Stabilizers

Valproate (Depakote), Lamotrigine (Lamictal, superior for bipolar depression), Carbamazepine, Oxcarbazepine

Atypical Antipsychotics

Quetiapine (most commonly used for both poles), Olanzapine, Aripiprazole, Lurasidone (FDA-approved for bipolar depression)

Side Effects

Lithium: tremor, polyuria, hypothyroidism, kidney impairment long-term; Valproate: weight gain, teratogenicity (contraindicated in women of childbearing age); Olanzapine: severe weight gain, metabolic syndrome⁶; Quetiapine: sedation, weight gain, diabetes risk

Conventional Treatment Framework

Acute mania: Lithium carbonate (start per your prescriber, titrate to level 0.8–1.2 mEq/L), requires regular serum monitoring and kidney/thyroid checks every 3–6 months
Acute mania: Valproate sodium (Depakote), faster onset than lithium; highly effective for mixed states; avoid in women of childbearing age (teratogen)
Acute mania: Atypical antipsychotics, Quetiapine, Olanzapine, Risperidone, Aripiprazole used for acute stabilization; sedating effects useful for sleep disruption in mania
Bipolar depression: Lamotrigine (Lamictal), best evidence for preventing bipolar depressive episodes; requires slow titration to avoid Stevens-Johnson syndrome (rare but serious rash)
Bipolar depression: Lurasidone (Latuda), FDA-approved specifically for bipolar I depression; metabolically cleaner than quetiapine
Bipolar depression: Caution with antidepressants, SSRIs and SNRIs alone (without a mood stabilizer) risk triggering mania, hypomania, or rapid cycling. If used, must be paired with a mood stabilizer.
Psychotherapy: Cognitive Behavioral Therapy for Bipolar (CBT-BP), Interpersonal and Social Rhythm Therapy (IPSRT, specifically addresses circadian disruption), Family-Focused Therapy (FFT); all reduce relapse rates
Maintenance: Long-term mood stabilizer therapy is typically required; lithium maintenance is associated with 3x reduction in suicide rates compared to other mood stabilizers

⚠️ Antidepressant caution: In bipolar disorder, antidepressants (SSRIs, SNRIs, tricyclics) prescribed without a mood stabilizer have a well-documented risk of triggering manic or hypomanic episodes and worsening rapid cycling. If you are taking antidepressants for depression and experience any elevated mood, decreased sleep need, or increased impulsivity, consult your psychiatrist immediately, you may have undiagnosed bipolar disorder.

Nutritional Strategy

Mood-Stabilizing Diet: Anti-Inflammatory & Brain-Supportive

Diet profoundly influences neuroinflammation, gut microbiome composition, mitochondrial function, and neurotransmitter synthesis, all of which directly modulate bipolar mood stability. The Mediterranean dietary pattern has the strongest evidence for mood disorder outcomes.

✅ Mood-Stabilizing Foods:

🐟 Fatty Fish (3–4 servings/week)

Wild salmon, sardines, mackerel, anchovies, and herring are the highest dietary sources of EPA and DHA. These omega-3s incorporate into neuronal membranes over weeks, improving membrane fluidity, enhancing receptor signaling, reducing neuroinflammation, and increasing BDNF synthesis. This is the single most impactful dietary change for bipolar mood outcomes.

🥬 Dark Leafy Greens & Colorful Vegetables

Spinach, kale, and Swiss chard provide magnesium, folate, and antioxidants essential for neurotransmitter synthesis and neuroprotection. Colorful vegetables (especially cruciferous, broccoli, Brussels sprouts) provide sulforaphane, which activates Nrf2, the master antioxidant pathway, reducing oxidative neuroinflammation in the bipolar brain.

🫐 Berries & Polyphenol-Rich Foods

Blueberries, strawberries, dark cherries, pomegranate, and cacao (≥85%) provide anthocyanins, resveratrol, and flavonoids that cross the blood-brain barrier and directly reduce neuroinflammatory signaling. Regular berry consumption is associated with increased BDNF and improved cognitive function, both depleted in bipolar disorder.

🥚 High-Quality Protein at Every Meal

Protein provides amino acid precursors for all neurotransmitters: tryptophan (→ serotonin → melatonin), tyrosine (→ dopamine → norepinephrine), glutamate (→ GABA). Stable blood glucose from regular protein intake prevents hypoglycemia-driven mood instability, a frequently overlooked trigger for mood episodes in both directions.

❌ Foods That Destabilize Mood:

🍺 Alcohol (Complete Avoidance)

Alcohol is one of the most potent destabilizers in bipolar disorder, initially sedating but producing rebound excitatory states, disrupting circadian rhythms, depleting B vitamins, zinc, and magnesium, and dramatically impairing sleep architecture. Alcohol use disorder affects 30–50% of people with bipolar disorder and is the most common cause of medication non-response and rapid cycling. Complete avoidance is strongly recommended.

🍭 Refined Sugar & Ultra-Processed Foods

High glycemic load foods produce rapid blood glucose spikes and crashes, directly affecting mood stability, energy, and cognitive function. Ultra-processed foods (seed oils, emulsifiers, artificial flavors) disrupt the gut microbiome, increase intestinal permeability, and drive the inflammatory cascade that destabilizes mood in bipolar disorder. A diet characterized by ultra-processed foods is associated with 2x higher depression risk.

☕ Caffeine⁷ (Limit Strictly)

High caffeine intake disrupts sleep architecture, increases cortisol, and can trigger hypomanic states or anxiety in bipolar patients, especially in the vulnerable prodromal period before a manic episode. Limit to one cup of coffee before noon. Caffeine also interferes with lithium excretion, patients on lithium who dramatically change caffeine intake can alter their lithium levels dangerously.

🌾 Gluten (Consider Elimination Trial)

Elevated anti-gliadin antibodies and markers of intestinal permeability are found at higher rates in bipolar patients than the general population. Non-celiac gluten sensitivity may contribute to gut-brain neuroinflammation in a subset. A 6-week strict elimination trial (with gluten challenge reintroduction) can determine individual sensitivity, some bipolar patients report significant mood stabilization upon gluten elimination.

Supplement Protocol

Evidence-Based Supplements for Bipolar Mood Stability

The following supplements have clinical trial support for bipolar disorder, addressing omega-3 deficiency, oxidative stress, mitochondrial dysfunction, neuroinflammation, and neurotransmitter synthesis. All are adjunctive to psychiatric care.

Supplement	Mechanism & Evidence	Suggested Dose	Timing	Notes
Omega-3 (EPA + DHA)	The most evidence-supported nutritional intervention for bipolar depression. EPA (not DHA) is the primary mood-active fraction, reducing neuroinflammatory cytokines, inhibiting phospholipase A2 (overactive in bipolar disorder), and restoring membrane omega-3:omega-6 balance. A 2003 Stoll et al. RCT showed omega-3 significantly improved both manic and depressive ratings. A 2019 Cochrane review concluded omega-3 reduces bipolar depressive symptoms as an adjunct to standard treatment. EPA-dominant formulas (EPA:DHA ≥ 2:1) are preferred.	per your prescriber total EPA + DHA (EPA-dominant)	With a fatty meal (fat-containing food triples absorption)	Use triglyceride-form fish oil (not ethyl ester) for superior bioavailability. Refrigerate after opening. Check Omega-3 Index after 3 months to confirm membrane incorporation (target >8%). Choose a product with third-party testing.
N-Acetyl Cysteine (NAC)	NAC is the most studied non-prescription supplement for bipolar disorder. As the rate-limiting precursor to glutathione (the brain's master antioxidant), NAC directly reduces mitochondrial oxidative stress, which is dramatically elevated in bipolar. The landmark Berk et al. 2008 double-blind placebo-controlled trial showed statistically significant improvements in bipolar depression, mania, and overall functioning. NAC also modulates glutamate transmission at the nucleus accumbens, relevant to the addiction comorbidities common in bipolar disorder.	per your prescriber	Away from meals (empty stomach for best absorption); morning and evening	May cause mild GI discomfort initially, start at per your prescriber and increase over 2 weeks. The specific formulation used in trials is NAC effervescent (Swisse, Now Foods). Take with Vitamin C to maintain NAC in reduced (active) form. Effects build over 8–12 weeks.
Magnesium Glycinate	Magnesium is the cofactor for over 300 enzymatic reactions including ATP production, glutamate-NMDA receptor gating, GABA synthesis, and HPA axis regulation. Intracellular magnesium depletion is common in bipolar patients and worsens with lithium use. Magnesium blocks hyperactive NMDA receptors, reducing the glutamate excitotoxicity that drives mania and neuronal damage in recurrent episodes. Multiple open trials and case series show mood-stabilizing effects. RBC magnesium (not serum) should be tested to detect intracellular depletion.	per your prescriber elemental magnesium/day (as glycinate)	With dinner; or split per your prescriber morning and per your prescriber evening	Glycinate is the best-tolerated and best-absorbed form. Avoid oxide (poorly absorbed, laxative) and citrate if stools are loose. Magnesium glycinate is calming, higher doses at night improve sleep quality, particularly valuable in hypomania when sleep is disrupted.
Lithium Orotate (Low-Dose)	Low-dose lithium orotate provides trace lithium levels without the therapeutic drug range required for prescription lithium carbonate. The orotate carrier facilitates superior membrane crossing. At these micro-doses, lithium exerts neuroprotective effects: inhibits GSK-3β (a kinase overactive in both bipolar disorder and Alzheimer's), increases BDNF synthesis, promotes neurogenesis in the hippocampus, and protects against glutamate excitotoxicity. Population-level studies show inverse correlation between lithium in drinking water and suicide/homicide rates.	per your prescriber elemental lithium/day (as orotate)	With food; evening preferred	Not equivalent to prescription lithium carbonate (which reaches blood levels of 0.8–1.2 mEq/L). Lithium orotate at these doses does not require blood monitoring. Must disclose use to psychiatrist, avoid concurrent use with NSAIDs (ibuprofen, naproxen) which reduce lithium clearance.
Methylfolate + Methylcobalamin	MTHFR gene polymorphisms (present in ~40% of the population) impair conversion of dietary folate to the active 5-methyltetrahydrofolate, leading to elevated homocysteine, an independent neurotoxin. Elevated homocysteine causes cerebrovascular microdamage, disrupts monoamine synthesis, and is associated with worse bipolar outcomes. Active methylfolate (5-MTHF) bypasses MTHFR, directly donating methyl groups for dopamine, serotonin, and norepinephrine synthesis. B12 as methylcobalamin supports this methylation cycle.	Methylfolate: per your prescriber; B12 (methylcobalamin): per your prescriber	Morning with breakfast	If starting methylfolate causes increased anxiety, irritability, or headache ("methyl-trapping"), reduce dose by 50% and increase gradually. Start doses low and increase monthly. Check homocysteine before and after supplementation, target <7 µmol/L.
Vitamin D3 + K2	Vitamin D receptors are densely expressed in the limbic system, hippocampus, prefrontal cortex, amygdala, and hypothalamus, the exact circuits dysregulated in bipolar disorder. Vitamin D activates transcription of BDNF, neuroprotective genes, and anti-inflammatory cytokines. Deficiency (extremely common: >70% of bipolar patients have levels below 30 ng/mL) is associated with more frequent mood episodes, greater depressive severity, cognitive impairment, and higher inflammation. K2 (MK-7) ensures calcium is directed to bone rather than soft tissue when taking higher D3 doses.	per your prescriber D3 + per your prescriber K2 (MK-7)/day	With the largest fat-containing meal of the day (fat-soluble vitamin)	Test 25(OH)D before supplementing, target maintenance level 40 to 60 ng/mL, the Endocrine Society's preferred range. Blood levels take 3 months to stabilize after dose change. Re-test at 3 months to ensure adequacy. Higher-body-weight individuals require higher doses (obesity sequesters Vitamin D in adipose tissue). If you take warfarin, agree any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonises warfarin, and changing your intake destabilises the INR. Consistency matters more than avoidance. This does not apply in the same way to direct oral anticoagulants such as apixaban or rivaroxaban.
Zinc Picolinate	Zinc modulates NMDA glutamate receptor activity (allosteric inhibitor, reduces excitotoxicity), regulates BDNF synthesis, and serves as a cofactor for the conversion of tryptophan to serotonin and of dopamine precursors. Meta-analyses confirm significantly lower serum zinc in major depressive disorder, and emerging bipolar-specific data show similar depletion patterns in depressive phases. A randomized trial found zinc augmentation improved antidepressant response and reduced depression scores. Zinc deficiency also impairs T-cell immune function, driving the chronic inflammatory state seen in bipolar disorder.	per your prescriber elemental zinc/day (as picolinate)	With food (to prevent nausea)	Picolinate form is best absorbed. High-dose zinc (above per your prescriber) depletes copper, if supplementing long-term at higher doses, add per your prescriber copper. Do not take zinc within 2 hours of thyroid medication (interferes with absorption). Zinc and lithium compete for transport, monitor if on prescription lithium.
CoQ10 (Ubiquinol)	Coenzyme Q10 is the electron carrier in the mitochondrial electron transport chain, essential for neuronal ATP production. Mitochondrial dysfunction is a core feature of bipolar disorder, and reduced CoQ10 is associated with greater disease severity. CoQ10 also functions as a potent lipid-phase antioxidant, protecting neuronal membranes from oxidative damage during the inflammatory cascades of mood episodes. Most effective when combined with NAC (glutathione support) and omega-3 for comprehensive neuroprotection.	per your prescriber (ubiquinol form)	With a fat-containing meal, essential for absorption	Ubiquinol (pre-reduced form) is 3–4x more bioavailable than ubiquinone, especially for individuals over 40 or on statin medications (which deplete CoQ10). Store in a cool, dark place. Pairs synergistically with NAC and omega-3 for mitochondrial neuroprotection.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed 27 August 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.⁸ This page already carries the two warnings that matter and they are repeated here because they are the whole safety picture. Never stop, reduce or change a mood stabiliser or antipsychotic without your prescriber: abrupt lithium discontinuation in particular causes rebound mania and raises suicide risk, and gradual, supervised change is a different thing from stopping. And antidepressants without a mood stabiliser can trigger mania or rapid cycling, which includes St John's wort, sold over the counter and frequently not mentioned to prescribers. Bipolar disorder carries the highest suicide risk of any psychiatric diagnosis; if you are having thoughts of harming yourself, contact emergency services or a crisis line now, which in the US is 988. Nutrition, sleep and routine genuinely support treatment. They are not treatment.

On the diagnosis: bipolar I requires a manic episode, bipolar II a hypomanic episode with major depression. Depression dominates the symptomatic burden in both, which is why bipolar disorder is frequently misdiagnosed as unipolar depression for years, and why asking about past hypomania before starting an antidepressant matters. ↩
On lithium. Lithium remains the best-evidenced mood stabiliser, and nothing in this note is a reason to change how you take it. Its anti-suicidal effect, though, is less settled than it once looked. A 2026 study emulating a randomised trial in US veterans found that adding lithium to existing treatment did not reduce suicide death over ten years, a risk ratio of 1.00 with a confidence interval of 0.86 to 1.15, agreeing with an earlier randomised trial, PubMed 42551960. That question is only about ADDING lithium in order to lower suicide risk. It says nothing about continuing it, and stopping lithium carries the rebound risk described at the end of this note. It requires monitoring of serum levels, kidney and thyroid function, and a 2026 review sets out the renal problems that make that monitoring necessary and how care is shared between psychiatry and nephrology when kidney function declines, PubMed 42589388. Its therapeutic window is narrow, and levels rise dangerously with dehydration, sodium restriction, NSAIDs, ACE inhibitors and thiazide diuretics. Sudden discontinuation is associated with rebound mania and increased suicide risk, so any change is planned and gradual. ↩
On antidepressants and St John's wort. Antidepressant monotherapy can precipitate manic switch or rapid cycling in bipolar disorder, and guidelines advise against using them without a mood stabiliser. St John's wort has antidepressant activity and has been associated with induction of mania, reported in an early series of three cases, PubMed 10653226, and again in a recent case of acute mania with psychosis, PubMed 41584739. It also induces cytochrome P450 3A4, reducing levels of many medicines including oral contraceptives and some antipsychotics; in healthy volunteers even the lowest dose tested almost doubled the clearance of a CYP3A probe drug, PubMed 39152679. It is sold without prescription and is routinely omitted from medication lists. ↩
On sleep, which is not a lifestyle detail here. Sleep deprivation is a well-documented trigger for manic episodes, listed alongside stress and antidepressant medication as a precipitant, PubMed 26001664, and disrupted circadian rhythm both precedes and follows mood episodes. Regular sleep and wake times, and treating comorbid sleep disorders, are among the more effective non-pharmacological interventions available, and social rhythm therapy has trial support. ↩
On omega-3 and other adjuncts: omega-3 fatty acids have modest evidence for bipolar depression and essentially none for mania, and N-acetylcysteine has mixed results after early promise; a systematic review of nutraceuticals in bipolar disorder found promising but conflicting evidence for both, too heterogeneous to pool, PubMed 32966097. Folate, B12 and vitamin D matter where deficient. All are adjuncts to pharmacological treatment, and none has evidence as monotherapy. ↩
On metabolic monitoring: several mood stabilisers and antipsychotics cause weight gain, dyslipidaemia and diabetes, and cardiovascular disease is a leading cause of premature death in bipolar disorder: a European multi-country cohort found it carried the highest absolute excess mortality in bipolar disorder, at 8.4 excess deaths per 10,000 person-years, PubMed 42480565. This is where nutrition does its most concrete work, alongside regular metabolic monitoring, rather than as an alternative to the medicines causing the effect. ↩
On caffeine and alcohol: caffeine disrupts sleep architecture and can destabilise mood, and it also raises renal lithium clearance, so that stopping it abruptly can raise serum lithium; two reported cases developed worsening lithium tremor after cutting out coffee, PubMed 3338980. Alcohol worsens course and interacts with treatment. Consistency matters as much as quantity. ↩
National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic.